ACTRN12605000358640招募中2 期
Efficacy And Safety Of Dihydrotestosterone (DHT) To Prevent Prostate Growth In Middle-Aged Men
Ascend/Besin0 个研究点目标入组 100 人开始时间: 2005年9月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 50 Years 至 ot stated（—）
- 性别
- Male
入选标准
- •Generally healthy men over age 50 years of age without known prostate disease.
排除标准
- •No exclusion criteria
研究者
相似试验
招募中
不适用
Result of testosterone (name of drug)in liver diseaseCTRI/2019/08/021000Institute of Liver and Biliary Sciences
进行中（未招募）
1 期
Does Testposterone improve the Pain Perception of Patients with Chronic Pain?Patient with persistent somatoform pain disorder (F45.40 or F45.41) should be included into the study.EUCTR2016-000048-32-DERWTH Aachen University/CTC-A60
进行中（未招募）
1 期
[18F] Dihyro-testosterone(FDHT) PET/CT- A novel Imaging technique in Patients with Porgressive Prostate CancerEUCTR2014-005684-32-GBThe Royal Marsden NHS Foundation Trust105
已完成
3 期
The efficacy and safety of low-dose dutasteride versus finasteride in the treatment of male androgenetic alopeciaMale androgenetic alopecia (Hamilton-Norwood classification IIIvertex-V)FinasterideDutasterideMale androgenetic alopeciaLow-dose dutasterideHair countHair densityHair diameterVideodermoscopyGlobal photographyTCTR20221106001Faculty of Medicine, Srinakharinwirot University58
尚未招募
3 期
The Efficacy of oral dutasteride in the treatment of female pattern androgenetic alopeciaAndrogenitic alopecia.IRCT20231119060107N1Tehran University of Medical Sciences40